Trump Administration Asks Supreme Court to Let Federal Prisons Taper Hormone Therapy for Transgender Inmates While Lawsuit Continues

Novo Nordisk Licenses Experimental Once-Weekly Obesity Pill From China’s Hengrui in Deal Worth Up to $2.6 BillionNovo Nordisk will pay $300 million upfront, and up to $2.6 billion in total, for Hengrui’s once-weekly GLP-1/GIP pill, which has not been tested in people. North Carolina Budget Sends Over $10.7 Million to Crisis Pregnancy Centers the State Health Department Does Not OverseeNorth Carolina’s budget gives more than $10.7 million to crisis pregnancy centers, but the state health department says it has no oversight of them. A Nonsmoker’s Lung Collapsed as He Blew Out His 20th Birthday Candles, and His Build May Explain WhyA healthy 20-year-old nonsmoker’s lung collapsed as he blew out birthday candles. Doctors say his tall, slim build may have set the stage. Three Weeks After Tonsil and Adenoid Surgery, a 2-Year-Old’s Fever and Stiff Neck Revealed Air Trapped Behind Her ThroatA toddler developed an infection and trapped air behind her throat three weeks after tonsil and adenoid surgery, a rare and delayed complication. Mental Health An Anxious Woman’s Pacing and Hand-Wringing Lit Up Her PET Scan in a Wonder Woman PatternA nervous patient paced and wrung her hands before a PET/CT scan, making her forearms and legs glow in what doctors called a Wonder Woman sign. A Prescribing Error Swapped an OCD Drug for a Fertility Pill, and the Patient Says Her Symptoms EasedA woman with OCD was mistakenly given clomiphene, a fertility drug, instead of clomipramine. She reported relief, raising questions about hormones. A Stroke Left Her Unable to Find the Keys on Her Phone, Even Though Her Language Tests Came Back NormalA 57-year-old woman’s stroke spared her language but left her unable to find keys or pick the right swipe on her Japanese phone keyboard. One in Nine Older Cannabis Users Meets Criteria for Cannabis Use Disorder, Though Most Cases Are MildAbout 11% of adults 65 and older who use cannabis meet criteria for cannabis use disorder, a national survey analysis finds. Most cases were mild. Innovation Floating Cartilage Nodules in a 35-Year-Old’s Knee Looked So Much Like Boba Pearls That Doctors Named a Sign After ThemA 35-year-old woman’s knee MRI showed round cartilage nodules floating like tapioca in bubble tea, a sign of synovial chondromatosis. EGFR Lung Cancer Patients Await a November 14 FDA Decision on Ivonescimab Plus Chemotherapy After Tagrisso Stops WorkingThe FDA is due to decide by Nov. 14 on ivonescimab plus chemotherapy for EGFR lung cancer after Tagrisso. What patients and families can ask now. AstraZeneca Seeks FDA Approval for Savolitinib Plus Tagrisso in Lung Cancer That Resists Tagrisso Through MET ChangesAstraZeneca has filed for FDA approval of savolitinib plus Tagrisso for EGFR-mutated lung cancer with MET-driven resistance. Full SAFFRON data are pending. Needle-Thin Brain Implant That Records, Stimulates, and Delivers Drugs Worked in Mice but Is Not Ready for PatientsA flexible brain implant that records signals, stimulates with light, and delivers drugs worked in mice. What it could mean for epilepsy research. Healthy Living Laptop Makers Warn Against Long Skin Contact, and a Boy’s Net-Like Stomach Rash Shows WhyA boy’s lace-like rash came from hours of laptop use on bare skin. HP and Apple manuals already warn against that kind of contact. An Orthopedic Surgeon Broke His Own Hand Refusing to Let Go of a Groom’s Shoe at a WeddingDuring a playful Joota Chori tug-of-war at an Indian wedding, a surgeon felt a snap but held on. X-rays showed a fractured metacarpal bone. Newsom Signs Law Barring Sales of Diet Pills and Weight-Loss Supplements to California Minors Without a PrescriptionCalifornia’s AB 2030 bars sales of diet pills and weight-loss or muscle-building supplements to minors without a prescription. What parents should know. Senators Give CDC Until October 9 to Explain Nearly Four-Week Delay in Free COVID Shots for Low-Income ChildrenSenators want the CDC to explain a nearly four-week delay in free COVID shots for low-income kids. Here is what parents of VFC-eligible children can do now. Covid – 19 FDA Proposes Requiring Companies to Report Food Additives That Now Reach Grocery Shelves Without Federal ReviewFDA has released its proposed GRAS rule requiring companies to notify the agency about food additives. Here is what the proposal does and does not do. Federal Regulators Warn Some Hair Dryer Brushes Lack the Part That Stops ElectrocutionCPSC warns hair dryer brushes sold on Walmart.com and TikTok Shop lack immersion protection. The seller has not agreed to a recall or refund. A Recalled Teething Toy Broke the Pattern Parents Were Told to Look ForA newly recalled pull-string teething toy has a different model number and design from earlier recalls, and one choking incident has been reported. Trying to Lower Blood Sugar, Cholesterol or Blood Pressure? Different Workouts Suited Different MarkersA pooled analysis of 53 trials found that different exercise types helped different metabolic markers. Most of the evidence was low certainty. cottonbro studio | Unsplash Share on Twitter Share on Facebook Share on Pocket The Trump administration on Sept. 28 asked the Supreme Court to let the federal Bureau of Prisons enforce a policy that ends hormone therapy, surgeries, and certain social accommodations for transgender inmates diagnosed with gender dysphoria. The emergency application seeks to pause a lower-court order that has kept that care in place while a class-action lawsuit continues, CBS News reported.

Chief Justice John Roberts, who handles emergency applications from the U.S. Court of Appeals for the D.C. Circuit, ordered the inmates’ attorneys to respond by 4 p.m. EDT on Oct. 8, according to the Supreme Court docket for Trump v. Kingdom. Roberts can act on the request alone or refer it to the full court.

The outcome has direct medical consequences. The Bureau of Prisons said it was providing hormone therapy to more than 600 inmates in 2025, and the new policy would taper those prescriptions rather than continue them.

The dispute began with a January 2025 executive order directing the Bureau of Prisons to stop spending federal funds on medical care meant to conform an inmate’s appearance to that of the opposite sex. In February 2026, the bureau issued a formal policy that it said reflected its own independent judgment.

Under the policy, the bureau would continue mental health services for inmates with gender dysphoria but would not provide surgeries, hormone therapy, or accommodations such as chest binders, wigs, or breast padding. New hormone treatment is barred, and inmates already receiving hormones would be placed on a tapering plan, according to The Advocate. The policy allows that some people who have had surgery or who experience severe withdrawal effects might initially continue receiving hormones, the outlet reported.

The case, known as Kingdom v. Trump in the lower courts, is a class action on behalf of federal inmates who have or will be diagnosed with gender dysphoria. It is separate from litigation over the administration’s effort to move transgender women into men’s prisons.

U.S. District Judge Royce Lamberth in Washington first blocked the restrictions in June 2025 and ordered the bureau to keep providing hormone therapy and accommodations. After the February 2026 policy was issued, he blocked it in June 2026, ruling in part that the bureau had “reverse engineered” a policy to carry out the executive order. He issued another order in August renewing that protection.

The Justice Department appealed. On Sept. 18, a divided panel of the D.C. Circuit voted 2 to 1 to leave Lamberth’s order in place. The administration then turned to the Supreme Court.

The Supreme Court’s conservative majority has previously upheld state laws restricting gender-affirming treatments for minors and has allowed the administration to enforce other policies affecting transgender people, including military service rules, while legal challenges continue. Those rulings do not decide this case, which involves adults in federal custody and the Eighth Amendment’s ban on cruel and unusual punishment.

In the application, Solicitor General D. John Sauer argued that questions of institutional security fall within the expertise of corrections officials and that courts should ordinarily defer to their judgment. He wrote that the lower court’s ruling “prevents the application of the Executive’s chosen policy on a universal and classwide basis.” Citing earlier rulings, the administration’s emergency application to the Supreme Court also states: “This Court has emphasized the importance of allowing politically accountable officials to make decisions about the permissible forms of treatment for gender dysphoria.”

The inmates are represented by the ACLU, the ACLU of D.C., and the Transgender Law Center. ACLU attorneys have called the policy “a direct threat to the well-being of transgender people in federal custody,” STAT reported, and they argue that withholding necessary care violates the constitutional ban on cruel and unusual punishment.

In his 2026 ruling, Lamberth wrote that the government does not contest that gender dysphoria exists and can have serious effects. The central legal question is whether the policy change reflected a legitimate medical and security judgment or, as the judge found, a pretext for carrying out the executive order.

Stopping long-term hormone therapy can have physical and mental health effects. The Marshall Project, reporting on the February policy, noted that stopping hormones can cause hot flashes, mood swings, and insomnia and may weaken bone density, raising the risk of fractures. Psychiatrist Dan Karasic told the outlet, “For those people for whom hormones and surgery are indicated, psychotherapy is not a substitute.”

People in custody cannot seek outside care on their own, so the bureau’s medical policy determines their treatment. Courts have long held that prisons must provide adequate care for inmates’ serious medical needs, and how the justices handle this request may shape how much deference prison officials receive when they change medical policies.

The inmates’ response is due Oct. 8, after which Roberts or the full court may rule at any time. Until then, Lamberth’s order remains in effect, meaning covered inmates keep receiving hormone therapy for now. A decision on the emergency request will not resolve the underlying lawsuit, but it will determine what care hundreds of inmates receive while the case continues.

What is the Trump administration asking the Supreme Court to do?

It wants the court to pause a lower-court order so the Bureau of Prisons can enforce a policy ending hormone therapy, surgeries, and some accommodations for transgender inmates while the lawsuit continues.

Is hormone therapy still being provided now?

Yes. Judge Royce Lamberth’s order remains in effect until the Supreme Court acts.

The Bureau of Prisons said it was providing hormone therapy to more than 600 inmates in 2025.

The inmates’ response is due Oct. 8. A ruling could come any time after that.

It says prison officials are best placed to judge institutional security and that the lower court improperly blocked the administration’s chosen policy.

Their lawyers say withholding necessary medical care violates the Eighth Amendment’s ban on cruel and unusual punishment.